Insider · CIK 0001825124

Salter Malcolm

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001825124

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-20	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.5K sh	—	—	32,500
2023-06-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-06-22	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2022-01-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+428 sh	$31.58	+$13.5K	11,380
2021-12-17	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$30.25	−$22.8K	10,952
2021-11-19	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$40.11	−$30.3K	11,707
2021-10-15	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$44.94	−$33.9K	12,462
2021-10-04	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+300 sh	$44.99	+$13.5K	13,217
2021-09-17	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$49.89	−$37.7K	12,917
2021-08-20	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$40.73	−$30.8K	13,672
2021-07-16	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$37.37	−$28.2K	14,427
2021-07-02	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+339 sh	$39.72	+$13.5K	15,182
2021-06-18	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$37.19	−$28.1K	14,843
2021-06-15	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-05-21	CCCCC4 Therapeutics, Inc.S Sale	Director	SSale	−755 sh	$37.12	−$28K	15,598
2021-04-05	CCCCC4 Therapeutics, Inc.A Award	Director	AAward	+359 sh	$37.51	+$13.5K	16,353
2020-10-06	CCCCC4 Therapeutics, Inc.C Conversion	Director	CConversion	+11.9K sh	—	—	11,856
2020-10-06	CCCCC4 Therapeutics, Inc.C Conversion	Director	CConversion	+2,823 sh	—	—	14,679
2020-10-06	CCCCC4 Therapeutics, Inc.P Purchase	Director	PPurchase	+1,315 sh	$19.00	+$25K	15,994
2020-10-06	CCCCC4 Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−100K sh	—	—	0
2020-10-06	CCCCC4 Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−23.8K sh	—	—	0
2020-10-01	CCCCC4 Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,786

Recent filings

Accepted (ET)
Jun 214
Salter Malcolm0001662579-24-000056
SEC(opens sec.gov)
Jun 164
Salter Malcolm0001662579-23-000055
SEC(opens sec.gov)
Jun 234
Salter Malcolm0001209191-22-038862
SEC(opens sec.gov)
Jan 184
Salter Malcolm0001209191-22-003504
SEC(opens sec.gov)
Dec 174
Salter Malcolm0001209191-21-070273
SEC(opens sec.gov)
Nov 194
Salter Malcolm0001209191-21-065820
SEC(opens sec.gov)
Oct 154
Salter Malcolm0001209191-21-060568
SEC(opens sec.gov)
Oct 54
Salter Malcolm0001209191-21-059530
SEC(opens sec.gov)
Sep 214
Salter Malcolm0001209191-21-057117
SEC(opens sec.gov)
Aug 244
Salter Malcolm0001209191-21-053162
SEC(opens sec.gov)
Jul 194
Salter Malcolm0001209191-21-047169
SEC(opens sec.gov)
Jul 74
Salter Malcolm0001209191-21-045808
SEC(opens sec.gov)
Jun 214
Salter Malcolm0001209191-21-042300
SEC(opens sec.gov)
Jun 174
Salter Malcolm0001209191-21-041425
SEC(opens sec.gov)
May 244
Salter Malcolm0001209191-21-035501
SEC(opens sec.gov)
Apr 64
Salter Malcolm0001209191-21-025663
SEC(opens sec.gov)
Oct 64
Salter Malcolm0000899243-20-027692
SEC(opens sec.gov)

Companies

C4 Therapeutics, Inc.DirectorCCCC

Address

C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200

WATERTOWN, MA, 02472